Literature DB >> 26598518

Regulation of c-Myc Expression by Ahnak Promotes Induced Pluripotent Stem Cell Generation.

Hee Jung Lim1, Jusong Kim1, Chang-Hwan Park2, Sang A Lee3, Man Ryul Lee3, Kye-Seong Kim2, Jaesang Kim4, Yun Soo Bae5.   

Abstract

We have previously reported that Ahnak-mediated TGFβ signaling leads to down-regulation of c-Myc expression. Here, we show that inhibition of Ahnak can promote generation of induced pluripotent stem cells (iPSC) via up-regulation of endogenous c-Myc. Consistent with the c-Myc inhibitory role of Ahnak, mouse embryonic fibroblasts from Ahnak-deficient mouse (Ahnak(-/-) MEF) show an increased level of c-Myc expression compared with wild type MEF. Generation of iPSC with just three of the four Yamanaka factors, Oct4, Sox2, and Klf4 (hereafter 3F), was significantly enhanced in Ahnak(-/-) MEF. Similar results were obtained when Ahnak-specific shRNA was applied to wild type MEF. Of note, expressionof Ahnak was significantly induced during the formation of embryoid bodies from embryonic stem cells, suggesting that Ahnak-mediated c-Myc inhibition is involved in embryoid body formation and the initial differentiation of pluripotent stem cells. The iPSC from 3F-infected Ahnak(-/-) MEF cells (Ahnak(-/-)-iPSC-3F) showed expression of all stem cell markers examined and the capability to form three primary germ layers. Moreover, injection of Ahnak(-/-)-iPSC-3F into athymic nude mice led to development of teratoma containing tissues from all three primary germ layers, indicating that iPSC from Ahnak(-/-) MEF are bona fide pluripotent stem cells. Taken together, these data provide evidence for a new role for Ahnak in cell fate determination during development and suggest that manipulation of Ahnak and the associated signaling pathway may provide a means to regulate iPSC generation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Myc (c-Myc); development; differentiation; embryonic stem cell; induced pluripotent stem cell (iPS cell) (iPSC)

Mesh:

Substances:

Year:  2015        PMID: 26598518      PMCID: PMC4705395          DOI: 10.1074/jbc.M115.659276

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  AHNAK, a protein that binds and activates phospholipase C-gamma1 in the presence of arachidonic acid.

Authors:  F Sekiya; Y S Bae; D Y Jhon; S C Hwang; S G Rhee
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

2.  LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism.

Authors:  Peter Cartwright; Cameron McLean; Allan Sheppard; Duane Rivett; Karen Jones; Stephen Dalton
Journal:  Development       Date:  2005-01-26       Impact factor: 6.868

Review 3.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

4.  A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.

Authors:  M H Rosner; M A Vigano; K Ozato; P M Timmons; F Poirier; P W Rigby; L M Staudt
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

Review 5.  Molecular control of induced pluripotency.

Authors:  Thorold W Theunissen; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2014-06-05       Impact factor: 24.633

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  AHNAK-mediated activation of phospholipase C-gamma1 through protein kinase C.

Authors:  In Hye Lee; Je Ok You; Kwon Soo Ha; Duk Soo Bae; Pann-Ghill Suh; Sue Goo Rhee; Yun Soo Bae
Journal:  J Biol Chem       Date:  2004-03-19       Impact factor: 5.157

10.  Multipotent cell lineages in early mouse development depend on SOX2 function.

Authors:  Ariel A Avilion; Silvia K Nicolis; Larysa H Pevny; Lidia Perez; Nigel Vivian; Robin Lovell-Badge
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

View more
  5 in total

1.  A Systems-level Characterization of the Differentiation of Human Embryonic Stem Cells into Mesenchymal Stem Cells.

Authors:  Anja M Billing; Shaima S Dib; Aditya M Bhagwat; Israel T da Silva; Rodrigo D Drummond; Shahina Hayat; Rasha Al-Mismar; Hisham Ben-Hamidane; Neha Goswami; Kasper Engholm-Keller; Martin R Larsen; Karsten Suhre; Arash Rafii; Johannes Graumann
Journal:  Mol Cell Proteomics       Date:  2019-07-22       Impact factor: 5.911

2.  AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma.

Authors:  Zijin Zhao; Songhua Xiao; Xianrui Yuan; Jian Yuan; Chi Zhang; Haoyu Li; Jun Su; Xiangyu Wang; Qing Liu
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

3.  AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.

Authors:  Bo Chen; Jin Wang; Danian Dai; Qingyu Zhou; Xiaofang Guo; Zhi Tian; Xiaojia Huang; Lu Yang; Hailin Tang; Xiaoming Xie
Journal:  J Exp Clin Cancer Res       Date:  2017-05-12

4.  Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma.

Authors:  Shruti Bhargava; Vikas Patil; Kulandaivelu Mahalingam; Kumaravel Somasundaram
Journal:  Oncotarget       Date:  2017-03-07

5.  Insights into the ubiquitin-proteasome system of human embryonic stem cells.

Authors:  Isabel Saez; Seda Koyuncu; Ricardo Gutierrez-Garcia; Christoph Dieterich; David Vilchez
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.